JP2018519847A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018519847A5 JP2018519847A5 JP2018510008A JP2018510008A JP2018519847A5 JP 2018519847 A5 JP2018519847 A5 JP 2018519847A5 JP 2018510008 A JP2018510008 A JP 2018510008A JP 2018510008 A JP2018510008 A JP 2018510008A JP 2018519847 A5 JP2018519847 A5 JP 2018519847A5
- Authority
- JP
- Japan
- Prior art keywords
- epitope
- mutation
- adenovirus
- oncolytic adenovirus
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562156748P | 2015-05-04 | 2015-05-04 | |
| US62/156,748 | 2015-05-04 | ||
| PCT/IB2016/052554 WO2016178167A1 (en) | 2015-05-04 | 2016-05-04 | Oncolytic adenoviruses with mutations in immunodominant adenovirus epitopes and their use in cancer treatment |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018519847A JP2018519847A (ja) | 2018-07-26 |
| JP2018519847A5 true JP2018519847A5 (enExample) | 2019-06-13 |
| JP6740340B2 JP6740340B2 (ja) | 2020-08-12 |
Family
ID=55967340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018510008A Active JP6740340B2 (ja) | 2015-05-04 | 2016-05-04 | 免疫優性アデノウイルスエピトープに突然変異を有する腫瘍溶解性アデノウイルスおよび癌処置におけるそれらの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11000560B2 (enExample) |
| EP (1) | EP3292142B1 (enExample) |
| JP (1) | JP6740340B2 (enExample) |
| CN (1) | CN107849111B (enExample) |
| AU (1) | AU2016257196B2 (enExample) |
| ES (1) | ES2987442T3 (enExample) |
| WO (1) | WO2016178167A1 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102272153B (zh) * | 2008-11-24 | 2015-04-15 | 德国慕尼黑亥姆霍兹研究中心健康和环境有限公司 | 高亲和力t细胞受体及其应用 |
| US10967298B2 (en) | 2012-03-15 | 2021-04-06 | Flodesign Sonics, Inc. | Driver and control for variable impedence load |
| US9950282B2 (en) | 2012-03-15 | 2018-04-24 | Flodesign Sonics, Inc. | Electronic configuration and control for acoustic standing wave generation |
| US9458450B2 (en) | 2012-03-15 | 2016-10-04 | Flodesign Sonics, Inc. | Acoustophoretic separation technology using multi-dimensional standing waves |
| US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
| CA2935960C (en) | 2014-01-08 | 2023-01-10 | Bart Lipkens | Acoustophoresis device with dual acoustophoretic chamber |
| US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
| US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
| US11021699B2 (en) | 2015-04-29 | 2021-06-01 | FioDesign Sonics, Inc. | Separation using angled acoustic waves |
| US11459540B2 (en) | 2015-07-28 | 2022-10-04 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
| US11474085B2 (en) | 2015-07-28 | 2022-10-18 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
| US10888549B2 (en) | 2016-03-07 | 2021-01-12 | The Johns Hopkins University | Pharmaceutical agents targeting cancer stem cells |
| US11085035B2 (en) | 2016-05-03 | 2021-08-10 | Flodesign Sonics, Inc. | Therapeutic cell washing, concentration, and separation utilizing acoustophoresis |
| US11214789B2 (en) | 2016-05-03 | 2022-01-04 | Flodesign Sonics, Inc. | Concentration and washing of particles with acoustics |
| CN110494543A (zh) | 2016-10-19 | 2019-11-22 | 弗洛设计声能学公司 | 通过声学的亲和细胞提取 |
| EP3833765B1 (en) * | 2017-08-09 | 2026-01-14 | Ohio State Innovation Foundation | Oncolytic virus carrying e-cadherin and uses thereof |
| CN109576231B (zh) | 2017-09-28 | 2022-03-25 | 北京康万达医药科技有限公司 | 分离的重组溶瘤腺病毒、药物组合物及其在治疗肿瘤和/或癌症的药物中的用途 |
| SG11202003907WA (en) | 2017-12-14 | 2020-05-28 | Flodesign Sonics Inc | Acoustic transducer drive and controller |
| DK3762004T3 (da) * | 2018-03-05 | 2023-11-27 | Klinikum Rechts Der Isar Der Technischen Univ Muenchen | Behandling af tumorer ved hjælp af en kombination af en oncolytisk adenovirus og en CDK4/6 inhibitor |
| GB201804468D0 (en) | 2018-03-21 | 2018-05-02 | Valo Therapeutics Oy | PeptiCRAd Cancer Therapy |
| US12295976B2 (en) | 2018-03-28 | 2025-05-13 | Epicentrx, Inc. | Personalized cancer vaccines |
| CN110856751B (zh) | 2018-08-24 | 2024-12-03 | 杭州康万达医药科技有限公司 | 包含核酸及tcr修饰的免疫细胞的治疗剂及其应用 |
| CN110669740B (zh) * | 2019-07-16 | 2021-10-08 | 伍泽堂 | 溶瘤病毒及其应用和治疗癌症的药物 |
| WO2021044061A1 (en) * | 2019-09-05 | 2021-03-11 | Klinikum Rechts Der Isar Der Technischen Universität München | Treatment of tumors by a combination of an oncolytic adenovirus, a cdk4/6 inhibitor and a further therapeutically active agent |
| CN114292830B (zh) * | 2021-12-31 | 2024-05-03 | 复旦大学 | 蛋白SaCas9的抗原表位及其在基因编辑中的应用 |
| EP4680727A2 (en) * | 2023-03-17 | 2026-01-21 | Walking Fish Therapeutics, Inc. | Methods for in vivo editing of b cells |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4588585A (en) | 1982-10-19 | 1986-05-13 | Cetus Corporation | Human recombinant cysteine depleted interferon-β muteins |
| US5681718A (en) | 1986-03-14 | 1997-10-28 | Celltech Limited | Methods for enhanced production of tissue plasminogen activator in cell culture using alkanoic acids or salts thereof |
| US7252989B1 (en) | 1994-04-04 | 2007-08-07 | Board Of Regents, The University Of Texas System | Adenovirus supervector system |
| US6127525A (en) * | 1995-02-21 | 2000-10-03 | Cornell Research Foundation, Inc. | Chimeric adenoviral coat protein and methods of using same |
| US5922315A (en) * | 1997-01-24 | 1999-07-13 | Genetic Therapy, Inc. | Adenoviruses having altered hexon proteins |
| US7749492B2 (en) | 2001-01-05 | 2010-07-06 | Nationwide Children's Hospital, Inc. | AAV vectors and methods |
| GB0216648D0 (en) | 2002-07-18 | 2002-08-28 | Lonza Biologics Plc | Method of expressing recombinant protein in CHO cells |
| SI2163260T1 (sl) * | 2004-01-23 | 2017-07-31 | Msd Italia S.R.L. | Nosilci šimpanzjih adenovirusnih cepiv |
| WO2005086922A2 (en) | 2004-03-10 | 2005-09-22 | Board Of Regents, University Of Texas System | Oncolytic adenovirus armed with therapeutic genes |
| WO2005075514A2 (en) | 2004-03-10 | 2005-08-18 | Lonza Ltd. | Method for producing antibodies |
| US20080292592A1 (en) * | 2004-04-30 | 2008-11-27 | Sunil Chada | Oncolytic Adenovirus Armed with Therapeutic Genes |
| WO2007015540A1 (ja) * | 2005-08-03 | 2007-02-08 | Medical And Biological Laboratories Co., Ltd. | 細胞傷害性ｔ細胞エピトープペプチド及びその用途 |
| WO2009117656A2 (en) * | 2008-03-21 | 2009-09-24 | Vectorlogics,Inc. | Capsid-incorporated antigen for novel adenovirus vaccine |
| JP2012513209A (ja) * | 2008-12-22 | 2012-06-14 | オンコス セラピュティックス オサケ ユキチュア | 腫瘍溶解アデノウイルスベクター並びに前記に関連する方法および使用 |
| ES2385251B1 (es) | 2009-05-06 | 2013-05-06 | Fundació Privada Institut D'investigació Biomèdica De Bellvitge | Adenovirus oncolíticos para el tratamiento del cáncer. |
| US20120107270A1 (en) * | 2009-06-30 | 2012-05-03 | Manuela Kaspar | Immunocytokines In Combination With Anti-ErbB Antibodies For The Treatment Of Cancer |
| US20130029358A1 (en) * | 2010-04-01 | 2013-01-31 | Ludwig Institute For Cancer Research Ltd. | Immunodominant mhc dr52b restricted ny-eso-1 epitopes, mhc class ii monomers and multimers, and uses thereof |
| CN103237889B (zh) * | 2010-08-16 | 2017-04-05 | 萨克生物研究学院 | 腺病毒组装方法 |
| EP2619224A1 (en) | 2010-09-24 | 2013-07-31 | Oncos Therapeutics Oy | Oncolytic adenoviral vectors and methods and uses related thereto |
| EP2643347B1 (en) * | 2010-11-25 | 2017-12-27 | Imnate Sarl | Modulation of antigen immunogenicity by deleting epitopes recognized by nkt cells |
| US11155599B2 (en) * | 2012-02-02 | 2021-10-26 | Board Of Regents, The University Of Texas System | Adenoviruses expressing heterologous tumor-associated antigens |
| US9017672B2 (en) * | 2012-05-11 | 2015-04-28 | Immunicum Aktiebolag | Hexon Tat-PTD modified adenovirus and uses thereof |
-
2016
- 2016-05-04 CN CN201680031591.6A patent/CN107849111B/zh active Active
- 2016-05-04 AU AU2016257196A patent/AU2016257196B2/en active Active
- 2016-05-04 WO PCT/IB2016/052554 patent/WO2016178167A1/en not_active Ceased
- 2016-05-04 EP EP16722384.1A patent/EP3292142B1/en active Active
- 2016-05-04 US US15/571,698 patent/US11000560B2/en active Active
- 2016-05-04 JP JP2018510008A patent/JP6740340B2/ja active Active
- 2016-05-04 ES ES16722384T patent/ES2987442T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6325459B2 (ja) | 腫瘍関連異種抗原を発現するアデノウイルス | |
| JP6740340B2 (ja) | 免疫優性アデノウイルスエピトープに突然変異を有する腫瘍溶解性アデノウイルスおよび癌処置におけるそれらの使用 | |
| Anderson et al. | Plasmid DNA and viral vector-based vaccines for the treatment of cancer | |
| JP6945301B2 (ja) | Ｈｐｖおよび関連する疾病のための免疫増強治療ワクチン | |
| JP7098330B2 (ja) | Ｈｐｖワクチン | |
| JP2015506704A5 (enExample) | ||
| JP6566214B2 (ja) | Ｒｅｉｃ遺伝子を発現する制限増殖型アデノウイルス | |
| JP5690814B2 (ja) | 抗原特異的な免疫応答を高めるための組成物及び方法 | |
| RU2016146664A (ru) | Аденовирус, содержащий альбумин-связывающий участок | |
| US10435672B2 (en) | Genetically stable oncolytic RNA virus, method of manufacturing and use thereof | |
| Riezebos-Brilman et al. | A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer | |
| CN101880688B (zh) | 一种使复制缺陷型腺病毒选择性复制的方法和用途 | |
| WO2026041811A1 (en) | Recombinant poxvirus and method for regulating the expression of toxic conditional gene products of said recombinant poxvirus in a producing cell | |
| CN121344098A (zh) | Gbm靶向性溶瘤腺病毒载体及其构建方法和应用 | |
| Guinn et al. | International society for cell and gene therapy of cancer (ISCGT) annual meeting: conference overview and introduction to the symposium papers | |
| Ji et al. | Oncolytic viruses in lung cancer: mechanisms of action and research progress | |
| HK40012146A (zh) | 表达异源肿瘤相关抗原的腺病毒 | |
| WO2025159067A1 (ja) | 腫瘍溶解性ウイルス及びそれを用いたがん治療 | |
| HK1205182B (en) | Adenoviruses expressing heterologous tumor-associated antigens | |
| Kim | Oncolytic vaccinia virus expressing 4-1BBL inhibits tumor growth by increasing CD8+ T cells in B16F10 tumor model | |
| Cai et al. | 136. The Oncolytic Adenovirus Targeting to TERT and Rb Pathway Induced Specific Cytotoxicity to Tumor Cells | |
| Aggen et al. | 356. CD8: Class I MHC Interactions In. fluence T Cell Activity Mediated by Chimeric Antigen Receptors | |
| Wang et al. | 138. Targeted Adenoviral Vectors Expressing Soluble TGFβRIIFc for Breast Cancer Metastasis | |
| Artlip et al. | 139. Manufacture of a Replication-Selective and Enhanced-Lytic Adenovirus Vector | |
| Quinn et al. | 137. Streamlined Method for the Simultaneous Construction and Purification of Multiple Recombinant Adenoviral Vectors |